Clinical analysis of lenvatinib therapy for unresectable thyroid cancer at Nagoya City University Hospital and related facilities-Reference-Cited by-同舟云学术

Clinical analysis of lenvatinib therapy for unresectable thyroid cancer at Nagoya City University Hospital and related facilities

Published:2022 Issue:1 Volume:48 Page:7-13
ISSN:1349-5747
Container-title:Toukeibu Gan
language:en
Short-container-title:Toukeibu Gan

Author:

Takano Gaku¹,Kawakita Daisuke²,Matoba Takuma²,Oguri Keisuke³,Murashima Akihiro²,Minohara Kiyoshi²,Tsuge Hiroshi⁴,Matsumura Ayano²,Hojo Wataru⁴,Tsukamoto Koji⁵,Harata Ikuma⁶,Maseki Shinichiro⁷,Ozawa Taijiro⁸,Mitsuya Shoji⁴,Moribe Kazuho⁹,Iwasaki Shinichi²

Affiliation:

1. Department of Otorhinolaryngology, Nagoya City University West Medical Center

2. Department of Otolaryngology, Head and Neck Surgery, Nagoya city University Graduate School of Medical Sciences

3. Department of Otorhinolaryngology, Konan Kosei Hospital

4. Department of Otorhinolaryngology, Anjo Kosei Hospital

5. Department of Otorhinolaryngology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital

6. Department of Otorhinolaryngology, Kainan Hospital

7. Department of Otorhinolaryngology, Toyota Kosei Hospital

8. Department of Otorhinolaryngology, Toyohashi Municipal Hospital

9. Department of Otorhinolaryngology, Ichinomiya Municipal Hospital

Publisher

Japan Society for Head and Neck Cancer